National Longevity Development Plans Global Landscape Overview 2019: Second Edition
As governments come and go and economies fluctuate, the extremely detailed metrics used in National Longevity Development Plans Global Landscape Overview puts the report’s conclusions at risk of obsolescence.
In order to keep our priorities for action in order, and to continue to provide relevant strategic analysis and recommendations to governments, it is necessary for Aging Analytics Agency to keep its analysis up to date. For this reason Aging Analytics Agency is releasing a second edition of the report, featuring an even wider range of even more precise metrics.
An updated analysis of the strengths and weaknesses of each nation is especially important for the benefit of the UK as it adopts a leading role on the global stage coordinating international Longevity planning on a global scale.
This upcoming analytical report will also aim to identify via statistical analyses the specific social policy, healthcare and financial reforms, and socioeconomic factors are most likely to enable such governments to develop integrated Longevity industries and ecosystems to scale, and to reduce as much as possible their national gap between life expectancy and Health-Adjusted Life Expectancy (HALE).
Longevity in UK Cross-Sector Comparative Analysis: Special Case Study
Unfortunately, no nation-level Longevity development strategy exists anywhere in the world. But we can nonetheless see the rudiments of one in the UK’s existing initiatives, which lay a good foundation for the development of such a plan, having taken several crucial early steps.
Indeed, just this week the UK Government published the green paper of its Preventive Medicine National Strategy, entitled “Advancing our health: prevention in the 2020s – consultation document”. In practice, this indicates that the UK will be the first country to officially implement P4 (Personalized, Preventive, Precision and Participatory) medicine into its national healthcare system.
This is the newest development in a series of large steps that the UK government has made in recent years towards the development of a proactive, progressive and technology-driven national Healthy Longevity development strategy, beginning with the formation of the Ageing Industrial Grand Challenge (prioritizing the problem of ageing population as one of four key national industrial development challenges for the nation) in 2017, followed by the launch of the £98 million Government-led Healthy Ageing Industrial Strategy Challenge Fund in 2018, and the launch of the All-Party Parliamentary Group for Longevity in 2019.
These are some of the major factors that led to the UK being ranked as #1 in Aging Analytics Agency’s National Longevity Development Plans: Global Overview (First Edition) analytical report, which used quantitative metrics to rank the strength, proactivity and relevance of various nations’ Longevity development projects and initiatives. This new green paper strengthens and reaffirms the conclusion made in that analytical report, on the UK’s leading position as a country that prioritizes the issue of ageing population and the opportunity of Healthy Longevity as key national priority items of the nation’s government.
There are a number of countries (including Singapore, Switzerland, South Korea, Israel, the Netherlands, Spain and Japan) that are currently ahead of the UK in terms of the gap between life expectancy and Health-Adjusted Life Expectancy (HALE), which can be considered one of the most robust measures of Healthy Longevity. However, this fact may be due to the comparatively smaller size of these countries populations, among other factors, which makes the implementation of national policy and preventive healthcare initiatives easier to implement.
However, one of the foremost reasons that the UK’s was ranked as #1 in Aging Analytics Agency’s “National Longevity Development Plans” analytical report, despite the country’s comparative large gap between life expectancy and Healthy Longevity, was because the nation is making boldly pogressive, science and technology-driven steps to launch initiatives that can rapidly decrease this gap, and not just putting forth optimistic rhetoric, but actually following-through on its promises with concrete and tangible actions.
Given the UK’s large GDP, the proactive efforts of its government to make Healthy Longevity a major priority of its national agenda, and the many steps they have taken to prove their seriousness on this topic, it is quite likely that the UK can become the clear leader in terms of government-ed National Longevity development plans, and can achieve very practical and tangible results in increasing their National Healthy Longevity within the next 5 years.
The UK’s potential leadership position in international Longevity development planning is also the reason why Aging Analytics Agency is publishing a dedicated Longevity in the UK cross-sector comparative analysis and special case study in the coming months to examine which sectors of the UK Longevity industry should be prioritized for maximum progress in the shortest time.
Early steps taken by the UK government include.
- The UK has recognized an “ageing society” as one of its 4 core industrial grand challenges, and allocated £300 million to overcome this challenge, out of which goes £98 towards “Healthy Ageing Industrial Strategy Challenge Fund.”
- This £98 million will drive the development of new products and services which will help people to live in their homes for longer, tackle loneliness, and increase independence and wellbeing.
- The UK has allocated £210 million towards “Data to early diagnosis and precision medicine programme.”
- The Centers of Excellence in Genomic Science (CEGS) program, which aims to develop novel and innovative genomic research projects using the data sets and technologies developed by the Human Genome Project.
- Innovate UK’s Digitalisation of Medicines Manufacturing Challenge Fund.
- In June 2018 Theresa May announced a commitment to harness AI to provide five more years of healthy independent lives by 2035.
Reviewing these initiatives, we can see that the UK has already turned its attention to cross-sector collaboration, particularly between artificial intelligence and healthcare. There has also been a general recognition of the central role of technology, and financial technology in particular, in improving the lives of the elderly.
However, there is no explicit intention of directing these agendas toward improving Healthy Longevity as a metric in itself yet. If the UK Government wants to optimise its existing initiatives for solving the aging population problem, it must create a veritable Industry of Healthy Longevity itself, which in turn requires:
- A greater focus on promoting biomedical innovations focused on extending Healthy Longevity, and on financial reform to neutralize economic risks posed by an aging society.
- A greater focus on combining these technologies in order to meet strategic goals. For example, it is not clear how much the UK government knows about the impact of its own biomedical initiatives on the ‘ageing society’ grand challenge.
Existing efforts must be extended to create a framework for changing the deficit model of the ‘Ageing Society’ to an asset model around ‘Longevity’. And to be bold with a national strategy to harness the ‘Longevity Dividend’ to benefit all people in the society. In other words, we need a fully integrated Longevity National Development Plan. This requires intelligent coordination.
In order for Aging Analytics Agency to serve as an effective advisor in these ongoing efforts, a continuous, detailed up-to-date analysis of the state of UK based on clear and robust metrics is an absolute necessity. It is for this reason that we intend to publish Longevity in UK Cross-Sector Comparative analysis: Special Case Study later this year.
- A wide range of independent Longevity-related government initiatives have recently been appearing around the world. This includes social and educational programs, urban planning solutions, biotechnological investment, programs, and national health data infrastructures.
- Aging Analytics Agency has documented these developments in their 2019 National Longevity Development Plans Global Landscape Overview analytical report and is offering its services to national and subnational governments aiming to coordinate this growing political will to achieve maximum effect and synergy.
- The United Kingdom has already turned its attention to cross-sector collaboration, particularly between artificial intelligence and healthcare. There has also been a general recognition of the central role of technology, and financial technology in particular, in improving the lives of the elderly.
- Aging Analytics Agency will continue to assist the UK to attain the best possible synergies as soon as they become possible, rather than unnecessarily limit its ambitions based on a misreading of the current state of progress, or the degree of progress necessary for immediate action.
- Aging analytics Agency will continue to produce reports focused on the role of government and the current state of Longevity development plans. The next two are National Longevity Development Plans Global Landscape Overview 2019: Second Edition, and Longevity in UK Cross-Sector Comparative Analysis: Special Case Study.
The Future of Longevity Governance – Forecasts by the Authors
We would like to share our vision on how we foresee the rise of successful, comprehensive and integrated Longevity economies and megahubs emerging from the spread of dedicated Longevity government development plans.
In the next few years, several technologically advanced small smart states will emerge as global competitors in the development of integrated Longevity Industry ecosystems, some of which will focus on specific sectors tuned to their unique strengths, while others will seek to create fully integrated hubs encompassing the entire multifaceted scope of the Longevity Industry.
Some will be sovereign states, some will be as independent regions of a bigger countries, apparently among will smart city-states such as Singapore, some of the Swiss cantons. We can envision some particular such city-hubs focusing primarily on R&D, as is the case of Basel, Switzerland, while others will be focused on practical applications (e.g. P4 medicine), such as in the case of the Swiss Lausanne.
The potential of government to bring about this type of development is not to be underestimated. The previously underdeveloped Zug canton in Switzerland for example – through a set of legislative initiatives, and some government coordination, as well as initiatives within the “crypto community” – quickly became known worldwide as the ‘Crypto Valley’. All that was required was for the cantonal authorities to foster a legislative environment (combined with some international promotional efforts) that would incentivize relevant expertise to relocate there and set up business. In other words, the government created conditions which attract a self-selecting population of community of crypto entrepreneurs.
The problem with cryptocurrency during those early years was that it was vulnerable to fraud, which weakened the crypto economy. But blockchain technology suffered no such setback, so Switzerland, by making itself a blockchain capital of the world, plugged that entire gap in the market, and henceforth is likely to remain at the centre of the new wave of safe cryptoeconomy.
Likewise we are seeing an explosion of similar initiatives in a number of “Longevity-progressive” countries, focusing on various facets of the Longevity industry, and in these cases too we should expect to see Longevity industrial clusters forming. And here too government is playing a similar role in achieving these clusters, through the formation of innovative ecosystems and legislative and/or industrial infrastructures, such as
- Establishment of flexible porgressive legal frameworks for clinical trials.
- Government support for more rapidly implementing practical applications in the clinic (to promote the practical application of AI for diagnostic, preventive medicine, precision treatments, and other advanced technologies).
- Establishment of financial institutions and instruments based upon the Longevity industry’s participants, products and services
Some countries are now selling their citizenship to foreign expats present and working in those countries for a certain period, thereby utilizing the same technique of selectively attracting human expertise that was used by Singapore in the creation of its technological mega-hub.
We expect five years from now to see a “new normal” of small technocratic nations selling their citizenship selectively to people committed to advancing Longevity-related technologies, in exchange for access to some of the most sophisticated and advanced healthcare, life insurance, MedTech, AgeTech and WealthTech ecosystems available.
One smaller-scale analogue of this type of development can be seen in the establishment of smaller “smart cities” by big corporations such as Apple, Facebook and Google, built to accommodate the specific needs and desired of their entire scope of employees, many of whom have migrated to work.
The ideal “Longevity-progressive country” would be able to undertake similar projects: smart towns and cities that integrate all subsectors of the multifaceted Longevity industry to create an optimized ecosystem for the maintenance of health and wealth. The development of these Longevity megahubs would incentivize the elderly to relocate in exchange for access to the best forms of AgeTech, WealthTech and other technologies, products, services and social policies capable of enabling the highest possible quality of life, social activity, mental wellness and overall functionality. Meanwhile, the middle-aged would be incentivized to relocate in exchange for access to the highest-quality MedTech, HealthTech and P4 medicine services, and the most sophisticated life and health insurance systems that reward their clients for the maintenance of an optimal state of health.
Among the assortment of global Longevity initiatives documented in National Longevity Development Plans Global Overview 2019 is described the emergence of so called “age-friendly cities” and “age-friendly towns”. This term refers to a formal commitment by the city authorities to attaining a particular WHO standard. Such towns and cities, however, in their present state of development, amount to little more than high-end retirement communities. A truly age-friendly city, and more importantly, the really “Longevity-friendly city”, would combine all the facets of the Longevity industry discussed previously, from AgeTech to P4 medicine, WealthTech, advanced InsurTech as well as societal infrastructures for maintaining an optimal state of wealth and health in the age of Healthy Longevity, empowering the elderly and the middle-aged physically, mentally and financially.
It is with this vision in mind – a globally coordinated Longevity industry led by Longevity-progressive countries, small versatile nations each intensively developing its own infrastructure for Longevity biotech hubs, Longevity finance hubs, precision medicine ecosystems, agetech towns and age-friendly cities – that Longevity.Capital and Aging Analytics Agency are engaging in active dialogue with government bodies and authorities of a number progerssive countries in order to establish fruitful collaborations in advance, to utilize the upcoming advantages of these emerging Longevity megahubs supported by smart technocratic progressive governments.
The most proactive and progressive scientists, industry players, companies, investors and stakeholders should consider being present in those countries poised to become Longevity MegaHubs already now, in advance, in order to be ahead of the curve. Those readers interested to find out what those countries are, should keep an eye on the upcoming second edition of Aging Analytics Agency’s “National Longevity Development Plans Global Overview, Extended Edition II”.
If you would like to remain up to date on the most advanced forefront of the Longevity Industry, please subscribe to this Longevity Industry Newsletter.
This article was written by Margaretta Colangelo and Dmitry Kaminskiy
Dmitry Kaminskiy is General Partner of Deep Knowledge Ventures, Founding Partner of Longevity.Capital, Founder of Aging Analytics Agency, and Founder of Deep Knowledge Analytics. Dmitry is the Head of International Development of the Secretariat for the UK All-Party Parliamentary Group for Longevity, Managing Trustee of the Biogerontology Research Foundation. Dmitry is based in London.
Margaretta Colangelo is Managing Partner of Deep Knowledge Ventures and Managing Partner of Longevity.Capital. She is Co-Founder of Aging Analytics Agency, Co-founder of Deep Knowledge Analytics, and Co-founder of Longevity.Capital. Margaretta serves on the Advisory Board of the AI Precision Health Institute at the University of Hawai‘i Cancer Center. Margaretta is based in San Francisco.
About Deep Knowledge Ventures
A leading investment fund focused on the synergetic convergence of DeepTech, frontier technologies and technological megatrends, renowned for its use of sophisticated analytical system for investment target identification and due-diligence. Major investment sectors include AI, Precision Medicine, Longevity, Blockchain and InvestTech.
About Aging Analytics Agency
Aging Analytics Agency is the world’s premier provider of industry analytics on the topics of Longevity, Precision Preventive Medicine and Economics of aging, and the convergence of technologies such as AI and Digital Health and their impact on healthcare. The company provides strategic consulting services in fields related to Longevity, and currently serves as the primary source of analytics for the specialized hybrid hedge fund Longevity.Capital, as well as the UK All-Party Parliamentary Group for Longevity.
Longevity.Capital is a specialized Longevity-Focused Hedge Fund with enhanced liquidity that uses hybrid investment technologies to combine the profitability of venture funds with the liquidity of hedge funds, significantly de-risking the interests of LPs and providing the best and most promising Longevity companies with relevant amounts of investment.